ImmunityBio, Inc. IBRX
- ANKTIVA — Non-Muscle Invasive Bladder Cancer NDA Submitted
- ANKTIVA — Non-Small Cell Lung Cancer Phase 2
- ANKTIVA — Glioblastoma Phase 2
- ANKTIVA — Pancreatic Cancer Phase 2
- ANKTIVA — Community-Acquired Pneumonia Phase 2
Home › Targets › IL-15 receptor
IL-15 receptor (1 companies · 5 programs)
Companies with an active program directed at IL-15 receptor.